Truist Financial’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-5,807
Closed -$200K 2664
2023
Q1
$200K Sell
5,807
-2,009
-26% -$65.2K ﹤0.01% 2432
2022
Q4
$218K Buy
+7,816
New +$207K ﹤0.01% 2386
2022
Q3
Sell
-8,830
Closed -$255K 2660
2022
Q2
$255K Sell
8,830
-17,247
-66% -$754K ﹤0.01% 2316
2022
Q1
$1.44M Sell
26,077
-982
-4% -$48.6K ﹤0.01% 1444
2021
Q4
$1.45M Sell
27,059
-75
-0.3% -$3.48K ﹤0.01% 1448
2021
Q3
$1.15M Sell
27,134
-12,053
-31% -$615K ﹤0.01% 1523
2021
Q2
$2.61M Sell
39,187
-36,531
-48% -$1.98M ﹤0.01% 1152
2021
Q1
$3.35M Sell
75,718
-6,238
-8% -$232K 0.01% 1008
2020
Q4
$2.38M Sell
81,956
-1,000
-1% -$24.9K ﹤0.01% 1097
2020
Q3
$1.82M Buy
82,956
+20,912
+34% +$372K ﹤0.01% 1108
2020
Q2
$718K Buy
62,044
+32,044
+107% +$351K ﹤0.01% 1435
2020
Q1
$196K Hold
30,000
﹤0.01% 2130
2019
Q4
$470K Buy
+30,000
New +$340K ﹤0.01% 1905

Other funds holding SGRY

Truist Financial's SGRY Position: Q2 2023 in Review

Truist Financial sold out of Surgery Partners (SGRY) in Q2 2023, closing a stake of 5,807 shares — an estimated $200K sold.

Truist Financial first reported a position in SGRY in Q4 2019 and held it in 13 quarters. The position peaked at $3.35M in Q1 2021. 168 funds tracked by Wall St. Rank hold SGRY as of Q2 2023.

  • Truist Financial reported no remaining Surgery Partners position as of Q2 2023 after selling out during the quarter.
  • Truist Financial sold 5,807 Surgery Partners shares in Q2 2023, an estimated $200K.
  • Truist Financial first reported a position in Surgery Partners in Q4 2019 and held it in 13 quarters.
  • Truist Financial's Surgery Partners position peaked at $3.35M in Q1 2021.
  • 168 funds tracked by Wall St. Rank held Surgery Partners as of Q2 2023.

Based on Truist Financial's 13F filing for Q2 2023, filed 1 Aug 2023.